NEWS
PROALT selected by the European Innovation Council to pitch at the EIC Investor Day with CUF
PROALT has been selected by the European Innovation Council (EIC) to pitch its innovative therapeutic solutions in oncology to top European investors at the EIC Investor Day with CUF. The event took place in Lisbon (Portugal) on 29 and 30 November 2022, where the Company has presented in the ‘Biotech & Pharmaceuticals session’ its antibodies [...]
PROALT participates in Anglonordic Life Science Conference 2022
Anti-CDH17 and anti-IL13Ra2 monoclonal antibodies developed by PROALT togheter with the Spanish Research Council (CSIC) are promising novel biological drugs to treat metastatic colorectal cancer (mCRC) and glioblastoma (GBM). Both could be new options for people whose cancers have not responded to previous lines of treatment. Delegates and Investors at the Anglonordic Life Science Conference [...]
ProAlt’s COO participates in a discussion panel at Asebio Investor Day 2022
PROTEIN ALTERNTIVES Chief Operating Officer Mr Juan Ignacio Imbaud has participated today in the second discussion panel "Boosting tech transfer in Biotechnology – turning ideas into technological solutions for society" at ASEBIO Investors Day organized by Asociación Española de Bioempresas. The panel was moderated by Carolina Pola, Innovation Strategist at Kaudal, and included reference speakers of the innovation ecosystem [...]
PROALT awarded with the Prize for the BEST BIOTECHNOLOGICAL STARTUP
Protein Alternatives SL (PROALT) received the Prize as the BEST BIOTECHNOLOGICAL STARTUP in the first edition of the #startups #awards of LA RAZON. The event was chaired by the Mayor of Madrid José Luis Martínez-Almeida, who was accompanied by Andrés Navarro, CEO of LA RAZÓN and the director Francisco Marhuenda. This first edition of the Sartup Awards has [...]
ProAlt will attended the 10th International Biotechnology Trade Show BioSpain 2021
September 14th, 2021 ProAlt will be present at BioSpain 2021 from the 29th September to the 1st October and will participate in the one-to-one meetings to present to investors and pharma companies the latest results of its anti-cadherins_RGD therapeutic antibodies in oncology. BioSpain is the 10th International Trade Show & Partnering Event that will take [...]
